Response to "Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective". [PDF]
Yuste MT +3 more
europepmc +1 more source
Evaluation of Ginsenosides and Their Derivatives From <i>Panax ginseng</i> as Aromatase Inhibitors for Breast Cancer Treatment-An <i>in silico</i> study. [PDF]
Madhan JG +7 more
europepmc +1 more source
An integrated computational, in vitro and metabolomics approach to the discovery of novel aromatase inhibitors with anti-breast cancer activities. [PDF]
Maiuthed A +8 more
europepmc +1 more source
Aromatase Inhibitors and Dementia Risk: Putting Safety Into Perspective. [PDF]
Rizk M, Mokbel K.
europepmc +1 more source
Comparative efficacy of Palbociclib and Everolimus with aromatase inhibitors in second line treatment of HR and HER2 negative metastatic breast cancer. [PDF]
Najafizade N +3 more
europepmc +1 more source
Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management. [PDF]
Nardin S +11 more
europepmc +1 more source
A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors. [PDF]
Montgomery GH +4 more
europepmc +1 more source
Grade 3 Dermatitis Secondary to Two Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: A Case Report. [PDF]
Gayford K +3 more
europepmc +1 more source
The Combination of Aromatase Inhibitors and GH Treatment for Idiopathic Short Stature in Male Adolescents. [PDF]
Cui Y, Zhang Q, Hou L, Luo X.
europepmc +1 more source
Identification of potential novel aromatase inhibitors as therapeutic strategies against breast cancer: insight into molecular docking, MD simulations and ADMET profiling. [PDF]
Ojedele OA +5 more
europepmc +1 more source

